Fortaleza Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Fortaleza Asset Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,230	Closed	-$550K	–	134
2017 Q3	$550K	Buy	1,230 +620	+102%	+$295K	1.01%	33
2017 Q2	$300K	Buy	+610	New	+$267K	0.57%	60
2015 Q1	–	Sell	-10	Closed	-$4K	–	219
2014 Q4	$4K	Hold	10	–	–	﹤0.01%	191
2014 Q3	$4K	Hold	10	–	–	﹤0.01%	209
2014 Q2	$3K	Sell	10 -3,300	-100%	-$978K	﹤0.01%	197
2014 Q1	$994K	Hold	3,310	–	–	0.51%	71
2013 Q4	$911K	Sell	3,310 -260	-7%	-$74.8K	0.46%	77
2013 Q3	$1.12M	Buy	3,570 +3,555	+23,700%	+$935K	0.58%	67
2013 Q2	$3K	Buy	+15	New	+$3.49K	﹤0.01%	185

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Fortaleza Asset Management's REGN Position: Q4 2017 in Review

Fortaleza Asset Management sold out of Regeneron Pharmaceuticals (REGN) in Q4 2017, closing a stake of 1,230 shares — an estimated $550K sold.

Fortaleza Asset Management first reported a position in REGN in Q2 2013 and held it in 9 quarters. The position peaked at $1.12M in Q3 2013. 639 funds tracked by Wall St. Rank hold REGN as of Q4 2017.

Fortaleza Asset Management reported no remaining Regeneron Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
Fortaleza Asset Management sold 1,230 Regeneron Pharmaceuticals shares in Q4 2017, an estimated $550K.
Fortaleza Asset Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 9 quarters.
Fortaleza Asset Management's Regeneron Pharmaceuticals position peaked at $1.12M in Q3 2013.
639 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2017.

Based on Fortaleza Asset Management's 13F filing for Q4 2017, filed 1 Feb 2018.